By- Mayanglangbam Merina
Imphal, June 29:
The Biosciences and Biotechnology Department at Indian Institute of Technology, Guwahati (or IITG), in its preliminary studies on CCTea has said that the tea has detected immunomodulatory properties, anti-viral effect and anti-tumour.
Following this, CCTea has entered into a one-year research collaboration with IIT Guwahati to further advance this breakthrough discovery to develop advanced therapeutic in three core areas – namely, immunomodulatory effect, anti-viral property, anti-tumour, and product development.
In the initial report shared by IIT Guwahati, it is observed that CCTea is non-toxic even at high concentration and does not alter the normal cell function. The results also suggest that it would be good for exploring its therapeutic potentials as a drug/natural formulation.
The research team at viral immunology laboratory at IIT Guwahati conducted several studies on CCTea’s immunomodulatory and anti-viral properties. It was revealed that CCTea have potent anti-viral compounds. The test was conducted using Japanese encephalitis virus (JEV) and Influenza virus as a model to test its anti-viral and immunomodulatory effects of CCTea. The preliminary test showed that it is anti-JEV and anti-influenza.
Further, it is also revealed that CCTea has shown positive responses and those points towards boosting the innate immunity. The main purpose of the innate immune response is to immediately prevent the spread and movement of foreign pathogens throughout the body. Further research are being undertaken to quantify these initial findings.
Says Dr. Sachin Kumar, Associate Professor, IIT Guwahati, “There is ample scope for research in this area. It is well known that a lot of herbs are being used as traditional medicines for the treatment of various diseases for generations. While it is early stages, the initial tests showed promising results. Therefore, we are continuing further experiment and we will share the findings at an appropriate time.”
When asked about the recent development, Ragesh Keisham – Chairman & CEO, CC Tea said, ‘We always believed that CC Tea is unique with multiple health benefits but we are really happy that our belief is now validated by IITGuwahati. Being one of the finest institutions in the country with state-of-the-art facilities, it is our privilege to have collaborated with IITGuwahati and with these; we are now in the race of humanity’s fight against this pandemic. While everyone is busy fighting to find a cure of Covid-19 where the infected is not even 1% of the population, we feel that the uninfected 99% are more vulnerable and our mission is to fight for the remaining 99% of the population by preventing them against this pandemic.’
CCTea, developed from a unique species of the finest quality of Cymbopogon Citratus, has been much loved by consumers in Manipur and across India. Since its inception in 2011, the company has grown tremendously with products being sold and retailed in India and in Europe.
As the world is being presently gripped by Covid19, and race is on to create a vaccine or cure, SuiGeneris Agronomy believes that until such time and beyond, CCTea can answer this and fill this gap to build immune, and its suggested anti-viral properties (by IITG) will be a major breakthrough in this.
CCTea is presently available in major stores across Manipur, and for customers across India, it can be purchased online at www.cctea.in.
CCTea is manufactured by the SuiGeneris Agronomy Private Limited and is headquartered in Imphal. The company provides meaningful employment to nearly 2000 individuals including hundreds of underprivileged women across Manipur.
For more details, please contact: Sam Khumanthem | Public Relations – Head | +91 6913347475